Although there is no clear evidence that ordering the PSA test would have affected the cancer prognosis, the majority of mock jurors in the first three groups (61%) believed that ordering the test would have saved the patient’s life or significantly improved the outcome. The gene discussed is KLK3; the disease is cancer.